These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 5973133

  • 1. [Estimation of insulin efficacy in obesity by the response of blood insulin and glucose to intravenous tolbutamide].
    Vague P, Depieds R, Boeuf G, Leroy C, Perrimond D, Codaccioni JL, Vague J.
    Ann Endocrinol (Paris); 1966; 27(6):820-9. PubMed ID: 5973133
    [No Abstract] [Full Text] [Related]

  • 2. [The insulinemic response after oral administration of glucose and after intravenous administration of tolbutamide in patients with Cushin's syndrome].
    Muggeo M, Tiengo A, Avogaro P, Crepaldi G, Enzi G, Trisotto A, Federspil G.
    Acta Isot (Padova); 1967 Dec 15; 7(1):99-116. PubMed ID: 5612077
    [No Abstract] [Full Text] [Related]

  • 3. Effect of long-term tolbutamide treatment on glucose tolerance and insulin secretion in maturity-onset diabetes without obesity.
    Lauvaux JP, Mandart G, Heymans G, Ooms HA.
    Horm Metab Res; 1972 Mar 15; 4(2):58-62. PubMed ID: 5028221
    [No Abstract] [Full Text] [Related]

  • 4. Effect of short-term tolbutamide treatment on insulin dynamics in newly diagnosed obese and non-obese adult diabetics.
    Wajchenberg BL, Nakasone K, Pasternak K.
    Horm Metab Res; 1970 Jan 15; 2(1):6-8. PubMed ID: 5520756
    [No Abstract] [Full Text] [Related]

  • 5. Effects of phenformin on insulin reserve and release.
    Boshell BR, Roddam RF, McAdams GL.
    Ann N Y Acad Sci; 1968 Mar 26; 148(3):756-67. PubMed ID: 5241474
    [No Abstract] [Full Text] [Related]

  • 6. Serum immunoreactive insulin response to oral glucose and intravenous sodium tolbutamide administration in relation to obesity.
    Devrim S, Koniçe M, Sencer E, Molvalìlar S, Alp H.
    Isr J Med Sci; 1972 Jun 26; 8(6):815-20. PubMed ID: 5051802
    [No Abstract] [Full Text] [Related]

  • 7. [Effects of glucose and arginine on the secretion of insulin in Cushing's syndrome].
    Modigliani E, Strauch G, Luton JP, Bricaire H.
    Diabetologia; 1970 Feb 26; 6(1):8-14. PubMed ID: 5434735
    [No Abstract] [Full Text] [Related]

  • 8. Metabolic clearance of insulin in man.
    Genuth SM.
    Diabetes; 1972 Oct 26; 21(10):1003-12. PubMed ID: 4561329
    [No Abstract] [Full Text] [Related]

  • 9. Insulin response to glucose, tolbutamide, secretin, and isoprenaline in maturity-onset diabetes mellitus.
    Deckert T, Lauridsen UB, Madsen SN, Mogensen P.
    Dan Med Bull; 1972 Oct 26; 19(7):222-6. PubMed ID: 5079926
    [No Abstract] [Full Text] [Related]

  • 10. [Immunologically measurable insulin(IMI) in normal, obese and obese, diabetic subjects after intravenous administration of glucose, tolbutamide and glucagon].
    Melani F, Lawecki J, Bartelt KM, Pfeiffer EF.
    Diabetologia; 1967 Oct 26; 3(5):422-6. PubMed ID: 5620801
    [No Abstract] [Full Text] [Related]

  • 11. [Critical considerations regarding the obesity-hyperinsulinism concept].
    Melani F.
    Acta Diabetol Lat; 1968 Oct 26; 5 Suppl 1():332-40. PubMed ID: 4907222
    [No Abstract] [Full Text] [Related]

  • 12. Response of plasma insulin, serum free fatty acids and blood glucose in growth onset diabetics, to I.V. tolbutamide.
    Kirti S, Dutta PK, Vaishnava H, Singh RB.
    J Assoc Physicians India; 1976 Mar 26; 24(3):141-6. PubMed ID: 1010812
    [No Abstract] [Full Text] [Related]

  • 13. [Dynamics of the content of immunoreactive insulin and sugar in the blood during tests with glucose, tolbutamide and leucine in patients with Cushing's syndrome].
    Arapova SD.
    Probl Endokrinol (Mosk); 1976 Mar 26; 22(4):27-33. PubMed ID: 800643
    [Abstract] [Full Text] [Related]

  • 14. [The dynamics of insulinemia in man after administration of tolbutamide].
    Lenti G, Pellegrini A, Pagano G, Mascia V, Cirillo R.
    Minerva Med; 1968 Feb 03; 59(10):479-87. PubMed ID: 5642230
    [No Abstract] [Full Text] [Related]

  • 15. [ON THE BEHAVIOR OF THE INSULIN-LIKE ACTIVITY OF THE BLOOD SERUM IN ADIPOSITY].
    BOTTERMANN P, SCHWARZ K, KOPETZ K.
    Dtsch Med Wochenschr; 1965 May 14; 90():917-21. PubMed ID: 14278083
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Immunologically reacting insulin in obese children].
    Waldhausl W, Huber EG.
    Z Kinderheilkd; 1968 Sep 23; 104(2):128-34. PubMed ID: 5716393
    [No Abstract] [Full Text] [Related]

  • 18. Response of plasma insulin to small doses of tolbutamide in obesity and acromegaly.
    Pelkonen R, Taskinen MR, Nikkilä EA.
    Int J Obes; 1977 Sep 23; 1(4):315-24. PubMed ID: 617112
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A new principle for the comparison of insulin secretory responses. II. The effect of obesity on insulin secretion.
    Johansen K.
    Acta Endocrinol (Copenh); 1973 Nov 23; 74(3):524-41. PubMed ID: 4800852
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.